{"id":8169,"date":"2023-05-05T02:33:32","date_gmt":"2023-05-04T23:33:32","guid":{"rendered":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/"},"modified":"2023-05-23T17:37:30","modified_gmt":"2023-05-23T14:37:30","slug":"erster-zugelassener-rsv-impfstoff-nach-sechs-jahrzehnten-wichtiger-errungenschaft-im-bereich-der-offentlichen-gesundheit","status":"publish","type":"post","link":"https:\/\/urbancare.clinic\/de\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/","title":{"rendered":"Erster RSV-Impfstoff nach sechs Jahrzehnten zugelassen: \u201eWichtige Errungenschaft f\u00fcr die \u00f6ffentliche Gesundheit\u201c"},"content":{"rendered":"<p>Ein monumentales Ereignis in der Geschichte der Gesundheitsbranche ereignete sich diese Woche, nachdem die US-amerikanische Food and Drug Administration (FDA) den ersten RSV-Impfstoff f\u00fcr \u00e4ltere Erwachsene zugelassen hatte, dessen Herstellung sechs Jahrzehnte dauerte.<\/p>\n<p>Am Mittwoch hat die FDA offiziell den RSV-Impfstoff zugelassen, an dessen Entwicklung Wissenschaftler in den letzten sechzig Jahren hart gearbeitet haben, wobei fr\u00fchere hochkar\u00e4tige Versuche nicht das Licht der Welt erblickten. <a rel=\"noopener nofollow\" href=\"https:\/\/abcnews.go.com\/amp\/Health\/1st-rsv-vaccine-older-adults-us-cleared-fda\/story?id=99049816\" target=\"_blank\">abc Nachrichten<\/a> gemeldet.<\/p>\n<p>GSK hat mit Arexvy den ersten zugelassenen RSV-Impfstoff f\u00fcr \u00e4ltere Erwachsene entwickelt. Das Pharmaunternehmen sagte, es habe bereits \u201eMillionen Dosen zum Versand bereit\u201c und warte auf die im Juni f\u00e4llige Empfehlung der Centers for Disease Control and Prevention (CDC).<\/p>\n<p>GSK sagte, es werde \u00fcber gen\u00fcgend Impfstoffdosen verf\u00fcgen, um den Bedarf zu decken, bis die Atemwegserkrankung in der Herbst- und Wintersaison weit verbreitet sei. Es ist jedoch erw\u00e4hnenswert, dass Pfizer und Moderna ebenfalls an \u00e4hnlichen Impfstoffen arbeiten. Die beiden k\u00f6nnten bald nach Erhalt der FDA-Zulassung ebenfalls auf den Markt kommen.<\/p>\n<p>Der Impfstoff von Moderna befindet sich bereits in der Phase-3-Studie. Sobald dies erledigt ist, werden die Ergebnisse der FDA vorgelegt und auf die Genehmigung gewartet. Mittlerweile ist der RSV-Impfstoff von Pfizer bereits fertig. Man wartet nur auf die Entscheidung der FDA, die Ende Mai fallen k\u00f6nnte.<\/p>\n<p>Arexvy ist f\u00fcr die Verabreichung als Einzelspritze an Erwachsene ab 60 Jahren konzipiert. Dr. Peter Marks, Direktor des Center for Biologics Evaluation and Research der FDA, erkl\u00e4rte, dass es f\u00fcr \u00e4ltere Erwachsene von entscheidender Bedeutung sei, diesen Impfstoff zu erhalten, da f\u00fcr sie ein hohes Risiko besteht, an schweren Erkrankungen zu erkranken, sobald sie sich mit dem Virus infizieren.<\/p>\n<p>\u201e\u00c4ltere Erwachsene, insbesondere solche mit Grunderkrankungen wie Herz- oder Lungenerkrankungen oder geschw\u00e4chtem Immunsystem, haben ein hohes Risiko f\u00fcr schwere, durch RSV verursachte Erkrankungen\u201c, sagte Marks in einer Erkl\u00e4rung von <a rel=\"noopener nofollow\" href=\"https:\/\/amp.cnn.com\/cnn\/2023\/05\/03\/health\/first-rsv-vaccine-approved\/index.html\" target=\"_blank\">CNN<\/a>.<\/p>\n<p>\u201eDie heutige Zulassung des ersten RSV-Impfstoffs ist eine wichtige Errungenschaft im Bereich der \u00f6ffentlichen Gesundheit zur Vorbeugung einer Krankheit, die lebensbedrohlich sein kann, und spiegelt das anhaltende Engagement der FDA wider, die Entwicklung sicherer und wirksamer Impfstoffe f\u00fcr den Einsatz in den Vereinigten Staaten zu erleichtern\u201c, f\u00fcgte er hinzu.<\/p>\n<p>RSV oder Respiratory Syncytial Virus ist ein Atemwegsvirus, das typischerweise leichte, erk\u00e4ltungs\u00e4hnliche Symptome verursacht. W\u00e4hrend sich die meisten Menschen schnell von der Infektion erholen, kann RSV lebensbedrohlich sein, insbesondere f\u00fcr \u00e4ltere Erwachsene und Kleinkinder <a rel=\"noopener nofollow\" href=\"https:\/\/www.cdc.gov\/rsv\/index.html\" target=\"_blank\">CDC<\/a>.<\/p>\n<p>Zu den h\u00e4ufigsten RSV-Symptomen innerhalb von vier bis sechs Tagen nach der Infektion geh\u00f6ren eine laufende Nase, verminderter Appetit, Husten, Niesen, Fieber und pfeifende Atemger\u00e4usche. Nach Angaben des Gesundheitsamtes kann die Infektion bei S\u00e4uglingen zu Reizbarkeit, verminderter Aktivit\u00e4t und Atembeschwerden f\u00fchren.<\/p>\n<figure class=\"imageBox\">\n<div class=\"innerBox\"><picture class=\"mapping-embed\" width=\"736\" height=\"491\"><source type=\"image\/webp\" media=\"(min-width: 1100px)\" sizes=\"736px\" srcset=\"https:\/\/d.medicaldaily.com\/en\/full\/469188\/vaccine.webp?w=736&amp;f=9c20006d54e99547dc75f1ca19f3e6db 736w\"><source type=\"image\/jpeg\" media=\"(min-width: 1100px)\" sizes=\"736px\" srcset=\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/05\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg 736w\"><source type=\"image\/webp\" media=\"(min-width: 768px)\" sizes=\"1000px\" srcset=\"https:\/\/d.medicaldaily.com\/en\/full\/469188\/vaccine.webp?w=1100&amp;f=f4f1b6fb483fd723f9340d362f3b31b9 1100w\"><source type=\"image\/jpeg\" media=\"(min-width: 768px)\" sizes=\"1000px\" srcset=\"https:\/\/d.medicaldaily.com\/en\/full\/469188\/vaccine.jpg?w=1100&amp;f=f4f1b6fb483fd723f9340d362f3b31b9 1100w\"><source type=\"image\/webp\" media=\"(min-width: 480px)\" sizes=\"736px\" srcset=\"https:\/\/d.medicaldaily.com\/en\/full\/469188\/vaccine.webp?w=736&amp;f=9c20006d54e99547dc75f1ca19f3e6db 736w\"><source type=\"image\/jpeg\" media=\"(min-width: 480px)\" sizes=\"736px\" srcset=\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/05\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg 736w\"><source type=\"image\/webp\" media=\"(min-width: 0px)\" sizes=\"480px\" srcset=\"https:\/\/d.medicaldaily.com\/en\/full\/469188\/vaccine.webp?w=480&amp;f=faae7d6e0aa742c5d8e79902fd89cb51 480w\"><source type=\"image\/jpeg\" media=\"(min-width: 0px)\" sizes=\"480px\" srcset=\"https:\/\/d.medicaldaily.com\/en\/full\/469188\/vaccine.jpg?w=480&amp;f=faae7d6e0aa742c5d8e79902fd89cb51 480w\"><source type=\"image\/webp\" srcset=\"https:\/\/d.medicaldaily.com\/en\/full\/469188\/vaccine.webp?w=736&amp;f=9c20006d54e99547dc75f1ca19f3e6db\"><img loading=\"lazy\" decoding=\"async\" class=\"mapping-embed imgPhoto\" id=\"i469188\" src=\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/05\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg\" alt=\"Impfstoff\" width=\"736\" height=\"491\" style=\"display:none\"><\/picture><\/div><figcaption class=\"caption\">\n<span class=\"cap\">Menschen mit Trypanophobie zeigen Symptome wie Schwindel, Herzklopfen, Schlaflosigkeit, Erbrechen, erh\u00f6hten Blutdruck und Panikattacken.<\/span><br \/>\n<span class=\"credit\">pixabay<\/span><br \/>\n<\/figcaption><\/figure>\n<p>Ver\u00f6ffentlicht von Medicaldaily.com<\/p>\n<p><a href=\"https:\/\/www.medicaldaily.com\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement-469648\">Medizinische t\u00e4gliche Quelle<\/a><\/p>\n<p>","protected":false},"excerpt":{"rendered":"<p>Ein monumentales Ereignis in der Geschichte der Gesundheitsbranche ereignete sich diese Woche, nachdem die US-amerikanische Food and Drug Administration (FDA) den ersten RSV-Impfstoff f\u00fcr \u00e4ltere Erwachsene zugelassen hatte, dessen Herstellung sechs Jahrzehnte dauerte.<\/p>\n<p>Am Mittwoch hat die FDA offiziell den RSV-Impfstoff zugelassen, an dessen Entwicklung Wissenschaftler in den letzten sechzig Jahren hart gearbeitet haben, wobei fr\u00fchere hochkar\u00e4tige Versuche nicht das Licht der Welt erblickten. <a rel=\"noopener nofollow\" href=\"https:\/\/abcnews.go.com\/amp\/Health\/1st-rsv-vaccine-older-adults-us-cleared-fda\/story?id=99049816\" target=\"_blank\">abc Nachrichten<\/a> gemeldet.<\/p>\n<p>GSK hat mit Arexvy den ersten zugelassenen RSV-Impfstoff f\u00fcr \u00e4ltere Erwachsene entwickelt. Das Pharmaunternehmen sagte, es habe bereits \u201eMillionen Dosen zum Versand bereit\u201c und warte auf die im Juni f\u00e4llige Empfehlung der Centers for Disease Control and Prevention (CDC).<\/p>\n<p>GSK sagte, es werde \u00fcber gen\u00fcgend Impfstoffdosen verf\u00fcgen, um den Bedarf zu decken, bis die Atemwegserkrankung in der Herbst- und Wintersaison weit verbreitet sei. Es ist jedoch erw\u00e4hnenswert, dass Pfizer und Moderna ebenfalls an \u00e4hnlichen Impfstoffen arbeiten. Die beiden k\u00f6nnten bald nach Erhalt der FDA-Zulassung ebenfalls auf den Markt kommen.<\/p>\n<p>Der Impfstoff von Moderna befindet sich bereits in der Phase-3-Studie. Sobald dies erledigt ist, werden die Ergebnisse der FDA vorgelegt und auf die Genehmigung gewartet. Mittlerweile ist der RSV-Impfstoff von Pfizer bereits fertig. Man wartet nur auf die Entscheidung der FDA, die Ende Mai fallen k\u00f6nnte.<\/p>\n<p>Arexvy ist f\u00fcr die Verabreichung als Einzelspritze an Erwachsene ab 60 Jahren konzipiert. Dr. Peter Marks, Direktor des Center for Biologics Evaluation and Research der FDA, erkl\u00e4rte, dass es f\u00fcr \u00e4ltere Erwachsene von entscheidender Bedeutung sei, diesen Impfstoff zu erhalten, da f\u00fcr sie ein hohes Risiko besteht, an schweren Erkrankungen zu erkranken, sobald sie sich mit dem Virus infizieren.<\/p>\n<p>\u201e\u00c4ltere Erwachsene, insbesondere solche mit Grunderkrankungen wie Herz- oder Lungenerkrankungen oder geschw\u00e4chtem Immunsystem, haben ein hohes Risiko f\u00fcr schwere, durch RSV verursachte Erkrankungen\u201c, sagte Marks in einer Erkl\u00e4rung von <a rel=\"noopener nofollow\" href=\"https:\/\/amp.cnn.com\/cnn\/2023\/05\/03\/health\/first-rsv-vaccine-approved\/index.html\" target=\"_blank\">CNN<\/a>.<\/p>\n<p>\u201eDie heutige Zulassung des ersten RSV-Impfstoffs ist eine wichtige Errungenschaft im Bereich der \u00f6ffentlichen Gesundheit zur Vorbeugung einer Krankheit, die lebensbedrohlich sein kann, und spiegelt das anhaltende Engagement der FDA wider, die Entwicklung sicherer und wirksamer Impfstoffe f\u00fcr den Einsatz in den Vereinigten Staaten zu erleichtern\u201c, f\u00fcgte er hinzu.<\/p>\n<p>RSV oder Respiratory Syncytial Virus ist ein Atemwegsvirus, das typischerweise leichte, erk\u00e4ltungs\u00e4hnliche Symptome verursacht. W\u00e4hrend sich die meisten Menschen schnell von der Infektion erholen, kann RSV lebensbedrohlich sein, insbesondere f\u00fcr \u00e4ltere Erwachsene und Kleinkinder <a rel=\"noopener nofollow\" href=\"https:\/\/www.cdc.gov\/rsv\/index.html\" target=\"_blank\">CDC<\/a>.<\/p>\n<p>Zu den h\u00e4ufigsten RSV-Symptomen innerhalb von vier bis sechs Tagen nach der Infektion geh\u00f6ren eine laufende Nase, verminderter Appetit, Husten, Niesen, Fieber und pfeifende Atemger\u00e4usche. Nach Angaben des Gesundheitsamtes kann die Infektion bei S\u00e4uglingen zu Reizbarkeit, verminderter Aktivit\u00e4t und Atembeschwerden f\u00fchren.<\/p>\n<figure class=\"imageBox\">\n<div class=\"innerBox\"><img loading=\"lazy\" decoding=\"async\" class=\"mapping-embed imgPhoto\" id=\"i469188\" src=\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/05\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg\" alt=\"Impfstoff\" width=\"736\" height=\"491\"><\/div><figcaption class=\"caption\">\n<span class=\"cap\">Menschen mit Trypanophobie zeigen Symptome wie Schwindel, Herzklopfen, Schlaflosigkeit, Erbrechen, erh\u00f6hten Blutdruck und Panikattacken.<\/span><br \/>\n<span class=\"credit\">pixabay<\/span><br \/>\n<\/figcaption><\/figure>\n<p>Ver\u00f6ffentlicht von Medicaldaily.com<\/p>","protected":false},"author":2,"featured_media":8170,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"page_builder":"","fifu_image_url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/05\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg","fifu_image_alt":"","footnotes":""},"categories":[27],"tags":[198,193],"class_list":["post-8169","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-blood-pressure","tag-vaccination"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>First RSV Vaccine Approved After Six Decades: &#039;Important Public Health Achievement&#039; - Urban Care Clinic<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/urbancare.clinic\/de\/erster-zugelassener-rsv-impfstoff-nach-sechs-jahrzehnten-wichtiger-errungenschaft-im-bereich-der-offentlichen-gesundheit\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First RSV Vaccine Approved After Six Decades: &#039;Important Public Health Achievement&#039; - Urban Care Clinic\" \/>\n<meta property=\"og:description\" content=\"A monumental event in the healthcare industry&#039;s history happened this week after the U.S. Food and Drug Administration (FDA) approved the first-ever RSV vaccine for older adults, which took six decades to make.On Wednesday, the FDA officially approved the RSV vaccine that scientists worked hard to develop in the past sixty years, with previous high-profile attempts not seeing the light of the day, ABC News reported.GSK developed the first approved RSV vaccine for older adults, Arexvy. The pharmaceutical company said it already has &quot;millions of doses ready to be shipped&quot; while waiting for the recommendation by the Centers for Disease Control and Prevention (CDC), due in June.GSK said it would have enough vaccine doses to meet the demand by the time the respiratory illness becomes prevalent during the fall and winter seasons. But it&#039;s worth noting that Pfizer and Moderna are also working on similar vaccines. The two could join the market soon after receiving the FDA&#039;s approval as well.Moderna&#039;s vaccine is already in its Phase 3 trial. Once done, it will submit the results to the FDA and wait for approval. Meanwhile, Pfizer&#039;s RSV vaccine is already complete. It is only waiting for the FDA&#039;s decision, which could come out by the end of May.Arexvy is designed to be administered as a single shot to adults aged 60 and above. FDA&#039;s Center for Biologics Evaluation and Research director Dr. Peter Marks explained that it&#039;s crucial for older adults to get this vaccine because they are at a high risk of suffering from serious conditions once they contract the virus.&quot;Older adults, in particular those with underlying health conditions, such as heart or lung disease or weakened immune systems, are at high risk for severe disease caused by RSV,&quot; Marks said in a statement obtained by CNN.&quot;Today&#039;s approval of the first RSV vaccine is an important public health achievement to prevent a disease which can be life-threatening and reflects the FDA&#039;s continued commitment to facilitating the development of safe and effective vaccines for use in the United States,&quot; he added.RSV, or respiratory syncytial virus, is a respiratory virus that causes typically mild, cold-like symptoms. While most people recover quickly from the infection, RSV can be life-threatening, especially for older adults and infants, according to the CDC.The most common symptoms of RSV within four to six days after getting infected include a runny nose, a decrease in appetite, coughing, sneezing, fever and wheezing. In infants, the infection could cause irritability, decreased activity and breathing difficulties, as per the public health agency. People with Trypanophobia show symptoms like dizziness, palpitations, insomnia, vomiting, increased blood pressure, and panic attacks. pixabay Published by Medicaldaily.com\" \/>\n<meta property=\"og:url\" content=\"https:\/\/urbancare.clinic\/de\/erster-zugelassener-rsv-impfstoff-nach-sechs-jahrzehnten-wichtiger-errungenschaft-im-bereich-der-offentlichen-gesundheit\/\" \/>\n<meta property=\"og:site_name\" content=\"Urban Care Clinic\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/urbancarezanzibar\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-04T23:33:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-23T14:37:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/05\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Urban Care Clinic\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Urban Care Clinic\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/\"},\"author\":{\"name\":\"Urban Care Clinic\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/person\\\/a304a61bcf298680ee41e2e9ae193930\"},\"headline\":\"First RSV Vaccine Approved After Six Decades: &#8216;Important Public Health Achievement&#8217;\",\"datePublished\":\"2023-05-04T23:33:32+00:00\",\"dateModified\":\"2023-05-23T14:37:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/\"},\"wordCount\":472,\"publisher\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg\",\"keywords\":[\"Blood Pressure\",\"Vaccination\"],\"articleSection\":[\"Medical Daily\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/\",\"name\":\"First RSV Vaccine Approved After Six Decades: 'Important Public Health Achievement' - Urban Care Clinic\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg\",\"datePublished\":\"2023-05-04T23:33:32+00:00\",\"dateModified\":\"2023-05-23T14:37:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/#primaryimage\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg\",\"contentUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg\",\"caption\":\"First RSV Vaccine Approved After Six Decades: &#8216;Important Public Health Achievement&#8217;\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/urbancare.clinic\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"First RSV Vaccine Approved After Six Decades: &#8216;Important Public Health Achievement&#8217;\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#website\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/\",\"name\":\"Urban Care Clinic\",\"description\":\"Your Medical Healthcare Clinic in Zanzibar\",\"publisher\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/urbancare.clinic\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\",\"name\":\"Urban Care Clinic Zanzibar\",\"alternateName\":\"Urban Care Clinic\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/Urban-Care-Clinic-Logo-Trans-512x512-1.png\",\"contentUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/Urban-Care-Clinic-Logo-Trans-512x512-1.png\",\"width\":500,\"height\":500,\"caption\":\"Urban Care Clinic Zanzibar\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/urbancarezanzibar\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/person\\\/a304a61bcf298680ee41e2e9ae193930\",\"name\":\"Urban Care Clinic\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"caption\":\"Urban Care Clinic\"},\"url\":\"https:\\\/\\\/urbancare.clinic\\\/de\\\/author\\\/urban-care-clinic\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Erster RSV-Impfstoff nach sechs Jahrzehnten zugelassen: \u201eWichtige Errungenschaft f\u00fcr die \u00f6ffentliche Gesundheit\u201c \u2013 Urban Care Clinic","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/urbancare.clinic\/de\/erster-zugelassener-rsv-impfstoff-nach-sechs-jahrzehnten-wichtiger-errungenschaft-im-bereich-der-offentlichen-gesundheit\/","og_locale":"de_DE","og_type":"article","og_title":"First RSV Vaccine Approved After Six Decades: 'Important Public Health Achievement' - Urban Care Clinic","og_description":"A monumental event in the healthcare industry's history happened this week after the U.S. Food and Drug Administration (FDA) approved the first-ever RSV vaccine for older adults, which took six decades to make.On Wednesday, the FDA officially approved the RSV vaccine that scientists worked hard to develop in the past sixty years, with previous high-profile attempts not seeing the light of the day, ABC News reported.GSK developed the first approved RSV vaccine for older adults, Arexvy. The pharmaceutical company said it already has \"millions of doses ready to be shipped\" while waiting for the recommendation by the Centers for Disease Control and Prevention (CDC), due in June.GSK said it would have enough vaccine doses to meet the demand by the time the respiratory illness becomes prevalent during the fall and winter seasons. But it's worth noting that Pfizer and Moderna are also working on similar vaccines. The two could join the market soon after receiving the FDA's approval as well.Moderna's vaccine is already in its Phase 3 trial. Once done, it will submit the results to the FDA and wait for approval. Meanwhile, Pfizer's RSV vaccine is already complete. It is only waiting for the FDA's decision, which could come out by the end of May.Arexvy is designed to be administered as a single shot to adults aged 60 and above. FDA's Center for Biologics Evaluation and Research director Dr. Peter Marks explained that it's crucial for older adults to get this vaccine because they are at a high risk of suffering from serious conditions once they contract the virus.\"Older adults, in particular those with underlying health conditions, such as heart or lung disease or weakened immune systems, are at high risk for severe disease caused by RSV,\" Marks said in a statement obtained by CNN.\"Today's approval of the first RSV vaccine is an important public health achievement to prevent a disease which can be life-threatening and reflects the FDA's continued commitment to facilitating the development of safe and effective vaccines for use in the United States,\" he added.RSV, or respiratory syncytial virus, is a respiratory virus that causes typically mild, cold-like symptoms. While most people recover quickly from the infection, RSV can be life-threatening, especially for older adults and infants, according to the CDC.The most common symptoms of RSV within four to six days after getting infected include a runny nose, a decrease in appetite, coughing, sneezing, fever and wheezing. In infants, the infection could cause irritability, decreased activity and breathing difficulties, as per the public health agency. People with Trypanophobia show symptoms like dizziness, palpitations, insomnia, vomiting, increased blood pressure, and panic attacks. pixabay Published by Medicaldaily.com","og_url":"https:\/\/urbancare.clinic\/de\/erster-zugelassener-rsv-impfstoff-nach-sechs-jahrzehnten-wichtiger-errungenschaft-im-bereich-der-offentlichen-gesundheit\/","og_site_name":"Urban Care Clinic","article_publisher":"https:\/\/www.facebook.com\/urbancarezanzibar","article_published_time":"2023-05-04T23:33:32+00:00","article_modified_time":"2023-05-23T14:37:30+00:00","og_image":[{"url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/05\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg","width":1024,"height":1024,"type":"image\/jpeg"}],"author":"Urban Care Clinic","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"Urban Care Clinic","Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/#article","isPartOf":{"@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/"},"author":{"name":"Urban Care Clinic","@id":"https:\/\/urbancare.clinic\/#\/schema\/person\/a304a61bcf298680ee41e2e9ae193930"},"headline":"First RSV Vaccine Approved After Six Decades: &#8216;Important Public Health Achievement&#8217;","datePublished":"2023-05-04T23:33:32+00:00","dateModified":"2023-05-23T14:37:30+00:00","mainEntityOfPage":{"@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/"},"wordCount":472,"publisher":{"@id":"https:\/\/urbancare.clinic\/#organization"},"image":{"@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/#primaryimage"},"thumbnailUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/05\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg","keywords":["Blood Pressure","Vaccination"],"articleSection":["Medical Daily"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/","url":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/","name":"Erster RSV-Impfstoff nach sechs Jahrzehnten zugelassen: \u201eWichtige Errungenschaft f\u00fcr die \u00f6ffentliche Gesundheit\u201c \u2013 Urban Care Clinic","isPartOf":{"@id":"https:\/\/urbancare.clinic\/#website"},"primaryImageOfPage":{"@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/#primaryimage"},"image":{"@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/#primaryimage"},"thumbnailUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/05\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg","datePublished":"2023-05-04T23:33:32+00:00","dateModified":"2023-05-23T14:37:30+00:00","breadcrumb":{"@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/#primaryimage","url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/05\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg","contentUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/05\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg","caption":"First RSV Vaccine Approved After Six Decades: &#8216;Important Public Health Achievement&#8217;"},{"@type":"BreadcrumbList","@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/urbancare.clinic\/"},{"@type":"ListItem","position":2,"name":"First RSV Vaccine Approved After Six Decades: &#8216;Important Public Health Achievement&#8217;"}]},{"@type":"WebSite","@id":"https:\/\/urbancare.clinic\/#website","url":"https:\/\/urbancare.clinic\/","name":"St\u00e4dtische Pflegeklinik","description":"Ihre medizinische Gesundheitsklinik in Sansibar","publisher":{"@id":"https:\/\/urbancare.clinic\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/urbancare.clinic\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/urbancare.clinic\/#organization","name":"Urban Care Clinic Sansibar","alternateName":"Urban Care Clinic","url":"https:\/\/urbancare.clinic\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/urbancare.clinic\/#\/schema\/logo\/image\/","url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2022\/07\/Urban-Care-Clinic-Logo-Trans-512x512-1.png","contentUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2022\/07\/Urban-Care-Clinic-Logo-Trans-512x512-1.png","width":500,"height":500,"caption":"Urban Care Clinic Zanzibar"},"image":{"@id":"https:\/\/urbancare.clinic\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/urbancarezanzibar"]},{"@type":"Person","@id":"https:\/\/urbancare.clinic\/#\/schema\/person\/a304a61bcf298680ee41e2e9ae193930","name":"St\u00e4dtische Pflegeklinik","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","caption":"Urban Care Clinic"},"url":"https:\/\/urbancare.clinic\/de\/author\/urban-care-clinic\/"}]}},"_links":{"self":[{"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/posts\/8169","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/comments?post=8169"}],"version-history":[{"count":0,"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/posts\/8169\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/media\/8170"}],"wp:attachment":[{"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/media?parent=8169"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/categories?post=8169"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/tags?post=8169"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}